OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Dr. Roger Crystal on Q4 2018 Results - Earnings Call Transcript
Opiant Pharmaceuticals, Inc. (OPNT)
Q4 2018 Results Conference Call
March 21, 2019 04:30 PM ET
Company Participants
Brian Ritchie - IR, LifeSci Advisors
Dr. Roger Crystal - CEO
David O'Toole - CFO
Conference Call Participants
David Bautz - Zacks Investment Research
Presentation
Operator
Greetings and welcome to the Opiant’s Pharmaceuticals Fourth Quarter and Full Year 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your